Mineralys Therapeutics CMO David Rodman sells $58,785 in stock

Mineralys Therapeutics CMO David Rodman sells $58,785 in stock
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.